| Financial Year |
March 31 2023 |
| Monetary Funds |
227,165,996.51 |
| Held-for-trading Financial Assets |
79,439,580.30 |
| Notes Receivable |
50,000.00 |
| Accounts Receivable |
209,750,956.71 |
| Advances to Suppliers |
5,851,387.45 |
| Other Receivables |
17,056,579.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
32,929,193.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,419,957.13 |
| Total Current Assets |
575,242,278.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,250,428.76 |
| Investment Properties |
-- |
| Fixed Assetes |
70,885,766.45 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,539,503.54 |
| R&D expenses |
-- |
| Goodwill |
9,648,873.91 |
| Long-Term Deferred and Prepaid Expenses |
753,611.10 |
| Deferred Income Tax Assets |
5,298,675.88 |
| Other Non-Current Assets |
5,493.00 |
| Sub-Total of Non-Current Assets |
186,965,493.85 |
| Total Assets |
762,207,772.22 |
| Short-Term Loans |
170,142,666.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
99,101,344.01 |
| Accounts Received In Advance |
99,837.66 |
| Employee Compensation Payable |
11,570,679.63 |
| Taxes Payable |
1,709,422.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
46,629,613.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,403,860.55 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
369,669,069.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
634,210.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,487,539.00 |
| Deferred Income Tax Liabilities |
3,081,678.91 |
| Other Non-Current Liabilities |
2,503,656.08 |
| Sub-Total of Non-Current Liabilities |
36,163,803.81 |
| Total Liabilities |
405,832,873.67 |
| Paid-In Capital(Or Share Stock) |
365,270,370.00 |
| Capital Surplus |
517,246,833.44 |
| Surplus Reserve |
58,624,735.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-753,393,539.79 |
| Minority Stockholder's Interest |
163,183,979.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
193,190,919.51 |
| Owner's Equity（Stockholder's Equity） |
356,374,898.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
762,207,772.22 |
